{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T10:08:37Z","timestamp":1756462117179},"reference-count":27,"publisher":"Societas Neurologica Japonica","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rinsho Shinkeigaku"],"published-print":{"date-parts":[[2013]]},"DOI":"10.5692\/clinicalneurol.53.803","type":"journal-article","created":{"date-parts":[[2013,11,12]],"date-time":"2013-11-12T23:06:42Z","timestamp":1384297602000},"page":"803-808","source":"Crossref","is-referenced-by-count":4,"title":["Leptomeningeal infiltlation of primary CNS B-cell lymphoma diagnosed by the biopsy of cauda equina: a case report"],"prefix":"10.5692","volume":"53","author":[{"given":"Hideki","family":"Nakajima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakatsu","family":"Motomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeharu","family":"Katoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuniko","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3663","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Mauney M, Sciotto CG. Primary malignant lymphoma of the cauda equina. Am J Surg Pathol 1983;7:185-190.","DOI":"10.1097\/00000478-198303000-00009"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Hopkins TJ, Raducun V, Sioutos N, et al. Lumbar lymphoma presenting as psoas abscess\/epidural mass with acute cauda equina syndrome. A case report. Spine 1993;18:774-778.","DOI":"10.1097\/00007632-199305000-00019"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Ampil F, Polin R, Nanda A. Cauda equina compression by malignant lymphoma: long-term survival following multimodality therapy. Leuk Lymphoma 2001;41:417-420.","DOI":"10.3109\/10428190109057997"},{"key":"4"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Tajima Y, Sudo K, Matumoto A. Malignant lymphoma originating in the cauda equina mimicking the inflammatory polyradiculoneuropathy. Intern Med 2007;46:1029-1032.","DOI":"10.2169\/internalmedicine.46.0005"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Tahiri L, Benbouazza K, Amine B, et al. Primary non-Hodgkin\u2019s lymphoma presenting as radicular syndrome: report of two cases. Rheumatol Int 2009;30:113-117.","DOI":"10.1007\/s00296-009-0898-3"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Ogilvie C, Lund K, McKay P, et al. Extranodal or primary CNS DLBC lymphoma? EJC Supplements 2010;8:19.","DOI":"10.1016\/S1359-6349(10)70690-X"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Iwasaki M, Hida K, Yano S, et al. Primary cauda equina lymphoma treated with high-dose methotrexate. Neurol Med Chir (Tokyo) 2012;52:679-683.","DOI":"10.2176\/nmc.52.679"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Shah GD, Yahalom J, Correa DD, et al. Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma. J Clin Oncol 2007;25:4730-4735.","DOI":"10.1200\/JCO.2007.12.5062"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) The Non-Hodgkin\u2019s Lymphoma Classification Project: A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma. Blood 1997;89:3909-3918.","DOI":"10.1182\/blood.V89.11.3909"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Miller DC, Hochberg FH, Harris NL, et al. Pathology with clinical correlations of primary central nervous system non-Hodgkin\u2019s lymphoma: The Massachusetts General Hospital experience 1958-1989. Cancer 1994;74:1383-1397.","DOI":"10.1002\/1097-0142(19940815)74:4<1383::AID-CNCR2820740432>3.0.CO;2-1"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Balmaceda C, Gaynor JJ, Sun M, et al. Leptomeningeal tumor in primary central nervous system lymphoma: recognition, significance, and implications. Ann Neurol 1995;38:202-209.","DOI":"10.1002\/ana.410380212"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Batchelor TT, Loeffler JS. Primary CNS lymphoma. J Clin Oncol 2006;24:1281-1288.","DOI":"10.1200\/JCO.2005.04.8819"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Scott BJ, Douglas VC, Tihan T, et al. A systematic approach to the diagnosis of suspected central nervous system lymphoma. JAMA Neurol 2013:70;311-319.","DOI":"10.1001\/jamaneurol.2013.606"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Wan JH, Trainor KJ, Brisco MJ, et al. Monoclonality in B cell lymphoma detected in paraffin wax embedded sections using the polymerase chain reaction. J Clin Pathol 1990;43:888-890.","DOI":"10.1136\/jcp.43.11.888"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Diss TC, Liu HX, Du MQ, et al. Improvement to B cell clonality analysis using PCR amplification of immunoglobulin light chain genes. J Clin Pathol 2002;55:98-101.","DOI":"10.1136\/mp.55.2.98"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Abrey LE, Yahalom J, DeAngelis LM. Treatment for primary CNS lymphoma: the next step. J Clin Oncol 2000;18:3144-3150.","DOI":"10.1200\/JCO.2000.18.17.3144"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Guha-Thakurta N, Damek D, Pollack C, et al. Intravenous methotrexate as initial treatment for primary central nervous system lymphoma: response to therapy and quality of life of patients. J Neurooncol 1999;43:259-268.","DOI":"10.1023\/A:1006210703827"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Batchelor T, Carson K, O\u2019Neill A, et al. Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07. J Clin Oncol 2003;21:1044-1049.","DOI":"10.1200\/JCO.2003.03.036"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Pels H, Schnidt-Wolf IG, Glasmacher A, et al. Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy. J Clin Oncol 2003;24:4489-4495.","DOI":"10.1200\/JCO.2003.04.056"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Herrlinger U, K\u00fcker W, Uhl M, et al. NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: final report. Ann Neurol 2005;57:843-847.","DOI":"10.1002\/ana.20495"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Glass J, Gruber ML, Cher L, et al. Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome. J Neurosurg 1994;81:188-195.","DOI":"10.3171\/jns.1994.81.2.0188"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) O\u2019Brien PC, Roos DE, Pratt G, et al. Combined-modality therapy for primary central nervous system lymphoma: long-term data from a Phase II multicenter study (Trans-Tasman Radiation Oncology Group). Int J Radiat Oncol Biol Phys 2006;64:408-413.","DOI":"10.1016\/j.ijrobp.2005.07.958"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Abrey LE, DeAngelis LM, Yahalom J. Long-term survival in primary CNS lymphoma. J Clin Oncol 1998;16:859-863.","DOI":"10.1200\/JCO.1998.16.3.859"},{"key":"25"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Le EN, Gerstenblith MR, Gelber AC, et al. The use of blind skin biopsy in the diagnosis of intravascular B-cell lymphoma. J Am Acad Dermatol 2008;59:148-151.","DOI":"10.1016\/j.jaad.2008.03.010"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Murase T, Nakamura S, Kawauchi K, et al. An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome. Br J Haematol 2000;111:826-834.","DOI":"10.1046\/j.1365-2141.2000.02426.x"}],"container-title":["Rinsho Shinkeigaku"],"original-title":["\u99ac\u5c3e\u751f\u691c\u304c\u8a3a\u65ad\u306b\u6709\u7528\u3067\u3042\u3063\u305f\u9ac4\u819c\u64ad\u7a2e\u6027\u306e\u60aa\u6027\u30ea\u30f3\u30d1\u816b\u306e1\u4f8b"],"language":"en","deposited":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T20:56:10Z","timestamp":1596833770000},"score":1,"resource":{"primary":{"URL":"http:\/\/jlc.jst.go.jp\/DN\/JST.JSTAGE\/clinicalneurol\/53.803?lang=en&from=CrossRef&type=abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.5692\/clinicalneurol.53.803","relation":{},"ISSN":["0009-918X","1882-0654"],"issn-type":[{"value":"0009-918X","type":"print"},{"value":"1882-0654","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}